Hormonal imbalance in two types of endometrial cancer and genetic polymorphism of steroidogenic enzymes

Maturitas

Volumn 54, Issue 4, 2006, Pages 352-355

  Berstein, Lev ^a   Zimarina, Tatjana ^a   Imyanitov, Evgeny ^a   Kovalevskij, Anatolij ^a   Maximov, Sergei ^a   Pujol, Pascal ^b   Thijssen, Jos ^c  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^b HÔPITAL ARNAUD DE VILLENEUVE   (France)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Endometrial cancer; Enzymes of steroid metabolism; Genetic polymorphisms; Types of disease

Indexed keywords

AROMATASE; CATECHOL ESTROGEN; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 17; CYTOCHROME P450 1B1;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; ENDOCRINE DISEASE; ENDOMETRIUM CANCER; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; HORMONE INHIBITION; HUMAN; HUMAN CELL; INCIDENCE; LEUKOCYTE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION;

ADULT; AGED; AROMATASE; ARYL HYDROCARBON HYDROXYLASES; CATECHOL O-METHYLTRANSFERASE; ENDOMETRIAL NEOPLASMS; FEMALE; GONADAL STEROID HORMONES; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; STEROID 17-ALPHA-HYDROXYLASE;

EID: 33745699889     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2006.04.017     Document Type: Article

References (17)

1. Berstein L.M., Imyanitov E.N., Suspitsin E.N., et al. CYP19 gene polymorphism in endometrial cancer patients. J Cancer Res Clin Oncol 127 (2001) 135-138
2. Berstein L.M., Imyanitov E.N., Gamajunova V.B., et al. CYP17 genetic polymorphism in endometrial cancer: are only steroids involved?. Cancer Lett 180 (2002) 47-53
3. Berstein L.M., Imyanitov E.N., Kovalevskij A.Ju., et al. CYP17 and CYP19 genetic polymorphisms in endometrial cancer: association with intratumoral aromatase activity. Cancer Lett 207 (2004) 191-196
4. Bokhman J.V. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15 (1983) 10-17
5. Bulun S.E., Economos K., Miller D., and Simpson E.R. CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors. J Clin Endocrinol Metab 79 (1994) 1831-1834
6. Dilman V.M. Development, ageing and disease. A new rationale for an intervention strategy (1994), Harwood Acad. Publ., Chur (Switzerland) 387 pp
7. Emons G., Fleckenstein G., Hinney B., Huschmand A., and Heyl W. Hormonal interactions in endometrial cancer. Endocrine-Related Cancer 7 (2000) 227-242
8. Haiman C.A., Hankinson S.E., Colditz G.A., Hunter D.J., DeVivo I. A polymorphism in CYP17 and endometrial cancer risk. Cancer Res., 200, 61, 3955-3960.
9. Koshiyama M., Konishii I., and Fujii S. Pathology, hormonal aspects, and molecular genetics of the two types of endometrial cancer. Cancer J 11 (1998) 277-283
10. Kristensen V.N., Harada N., Yoshimura N., et al. Genetic variants of CYP19 (aromatase) and breast cancer risk. Oncogene 19 (2000) 1329-1333
11. Kuligina E.S., Togo A.V., Suspitsin E.N., et al. CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women. Cancer Lett 156 (2000) 45-50
12. McGrath M., Hankinson S.E., Arbeitman L., Colditz G.A., Hunter D.J., and De Vivo I. Cytochrome P450 1B1 and catechol-O-methyltransferase polymorphisms and endometrial cancer susceptibility. Carcinogenesis 25 (2004) 559-565
13. Sasaki M., Tanaka Y., Kaneuchi M., Sakuragi N., and Dahiya R. CYP1B1 gene polymorphisms have higher risk for endometrial cancer, and positive correlations with estrogen receptor alpha and estrogen receptor beta expressions. Cancer Res 63 (2003) 3913-3918
14. Sherman M.E. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 13 (2000) 295-308
15. Shimada T., Watanabe J., Inoue K., Guengerich F.P., and Gillam E.M. Specificity of 17beta-estradiol and benzo[a]pyrene oxidation by polymorphic human cytochrome P450 1B1 variants substituted at residues 48, 119 and 432. Xenobiotica 31 (2001) 163-176
16. Zimarina T.S., Kristensen V.N., Imyanitov E.N., and Berstein L.M. Analysis of CYP1B1 and COMT genetic polymorphisms in patients with breast or endometrial cancer. Mol Biol 38 3 (2004) 1-8
17. Zhu B.T., and Conney A.H. Functional role of estrogen metabolism in target cells: review and perspectives. Carcinogenesis 19 (1998) 1-27